Amlexanox

Amlexanox
Amlexanox
Systematic (IUPAC) name
2-amino-7-isopropyl-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid
Clinical data
Trade names Aphthasol
AHFS/Drugs.com monograph
MedlinePlus a601017
Pregnancy cat.  ?
Legal status  ?
Routes Topical
Pharmacokinetic data
Half-life 3.5 hours
Excretion Renal (17%)
Identifiers
CAS number 68302-57-8 YesY
ATC code A01AD07
PubChem CID 2161
DrugBank APRD00795
ChemSpider 2076 YesY
UNII BRL1C2459K YesY
KEGG D01828 YesY
ChEBI CHEBI:31205 YesY
ChEMBL CHEMBL1096 YesY
Chemical data
Formula C16H14N2O4 
Mol. mass 298.293 g/mol
SMILES eMolecules & PubChem
 N(what is this?)  (verify)

Amlexanox (trade name Aphthasol) is a medication with antiallergic and anti-inflammatory effects used in the treatment of aphthous ulcers (canker sores). Amlexanox is also available in Japan as oral tablets (trade name Solfa) for treatment of bronchial asthma, where it has been marketed by the Takeda Pharmaceutical Company since 1987, though Aphthtab by Egyptian Eva pharma also exist. In India it is available as Lexanox by Macleods Pharmaceuticals Ltd. In Bangladesh it is marketed by Square Pharmaceuticals as Apsol.

References

External links